Sign in to continue:

Tuesday, July 28th, 2026

China Isotope & Radiation Corporation Subsidiary Secures Neutron Dosimetry Laboratory Project in Thailand to Boost Nuclear Technology Applications 12





China Isotope & Radiation Corporation Announces Key International Project

China Isotope & Radiation Corporation Announces Strategic Advancement with Major International Contract

Key Contract Signed for Secondary Standardized Neutron Dosimetry Laboratory Project in Thailand

China Isotope & Radiation Corporation (CIRC, Stock Code: 1763) has made a significant announcement regarding its latest business development that could have important implications for shareholders and investors. The company, through its subsidiary Chengdu Gaotong Isotope Co., Ltd. (CNGT), recently entered into a high-profile contract for a Secondary Standardized Neutron Dosimetry Laboratory Project in Thailand.

Key Points of the Announcement

  • Contract Participants: CNGT (subsidiary of CIRC) and China National Nuclear Corporation Overseas Ltd. (China National Nuclear, a wholly-owned subsidiary of China National Nuclear Corporation, CIRC’s controlling shareholder) have entered into the contract with Pondpol Analytical Co., Ltd. (Pondpol), an independent third party.
  • Project Scope: The contract covers technical services for the establishment of a Secondary Standardized Neutron Dosimetry Laboratory, a critical infrastructure project in Thailand aimed at enhancing the country’s application capabilities of nuclear technology and improving its national metrology system.
  • Division of Responsibilities: CNGT will be primarily responsible for providing the necessary products and related services to Pondpol. China National Nuclear will focus on project management and supervision, without participating in the provision of products and services.
  • Financial and Legal Arrangements: Each party will receive consideration and assume liability only for their respective portions of the project. There is no arrangement for joint performance or joint liability, and as such, the transaction does not constitute a connected transaction or a notifiable transaction under Chapter 14 or 14A of the Hong Kong Listing Rules.
  • Project Significance: The project is expected to play a vital role in calibrating neutron radiation dose measuring instruments and supporting scientific research, making it a milestone in Thailand’s nuclear infrastructure.
  • Strategic Implications: The successful execution of this project will serve as a model for CIRC’s expansion into Southeast Asia, particularly Thailand, and provides valuable experience for future international projects. This aligns with CIRC’s internationalization strategy and could pave the way for increased market share and revenue in the region.

Potential Impact on Shareholders and Share Price

  • International Expansion: This is a significant step in CIRC’s international growth strategy, which could positively influence market perception and investor sentiment.
  • Market Leadership: By undertaking a high-profile infrastructure project in Southeast Asia, CIRC is positioning itself as a leader in nuclear technology and metrology, which may enhance its reputation and open up further business opportunities.
  • No Joint Liability Risk: The clear separation of responsibilities and liabilities reduces risk exposure for CIRC, which is an important factor for risk-conscious investors.

Company Leadership and Board

The announcement was issued with the approval of the Board of Directors, led by Chairman Xiao Yafei. The Board consists of a mix of executive, non-executive, and independent non-executive directors, which provides strong governance for major strategic decisions.

Conclusion

The successful implementation of this project represents a milestone achievement for CIRC and underscores its commitment to international growth and technological leadership. Investors should closely monitor developments related to this contract and CIRC’s ongoing international strategy, as positive outcomes could potentially drive share value higher in the medium to long term.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence or consult professional advisors before making investment decisions. The information is based on the company’s official announcement and may be subject to updates or changes.




View CIRC Historical chart here